P3 Health Partners Inc (PIII)
0.3569
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.3569
0.00 (0.00%)
After-Hours: 18:56
P3 Health Partners Revenue (Quarterly): 379.16M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 379.16M |
| March 31, 2024 | 388.49M |
| December 31, 2023 | 346.86M |
| September 30, 2023 | 288.35M |
| June 30, 2023 | 329.09M |
| March 31, 2023 | 302.08M |
| December 31, 2022 | 258.21M |
| Date | Value |
|---|---|
| September 30, 2022 | 248.26M |
| June 30, 2022 | 269.45M |
| March 31, 2022 | 273.54M |
| September 30, 2021 | 156.19M |
| June 30, 2021 | 144.59M |
| March 31, 2021 | 151.30M |
| June 30, 2020 | 116.86M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
116.86M
Minimum
Jun 2020
388.49M
Maximum
Mar 2024
260.89M
Average
271.50M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 7.056M |
| Novo Integrated Sciences Inc | 3.152M |
| Astrana Health Inc | 486.26M |
| Cryo-Cell International Inc | 8.067M |
| Biote Corp | 49.17M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.02M |
| Total Expenses (Quarterly) | 410.49M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 316.56M |
| Profit Margin (Quarterly) | -3.17% |
| Earnings Yield | -187.7% |
| Normalized Earnings Yield | -202.81 |